Sen. Chuck Grassley, R-Iowa, chair of the Senate Finance Committee, prepares for the Feb. 26, 2019 hearing with CEOs from several U.S. drug makers.
Pablo Martinez Monsivais/AP Photo
As concern grows for the escalating prices of prescription drugs, a novel approach to lower the price of drugs to treat hepatitis C in Louisiana holds promise, a policy expert says.
Cancer patient Cao Dongxian poses with CT scan images of his intestine at a hotel room where he stays, near the Peking Union Hospital.
Developing brand new treatments and cures isn't the only way to achieve a major reduction in cancer deaths worldwide.
The proposed Australian price for Sovaldi has not been disclosed, but in the United States a three-month course of treatment costs US$84,000.
It’s twice as common as type 1 diabetes. It kills more Australians than HIV. One in every 100 of us lives with hepatitis C, but the disease receives little attention. Worldwide, around 150 million people…